Killingsworth L M
Clin Chem. 1982 May;28(5):1093-102.
Over the past decade, significant improvements in immunochemical and electrophoretic techniques have enabled collection of heretofore unavailable data on proteins in biological fluids, greatly increasing our understanding of protein physiology in the various body compartments and providing the foundation for clinical use of protein analysis in body fluids. The most striking advance has been in the diagnosis of demyelinating disease through the use of serum/cerebrospinal fluid protein ratios and the morphological evaluation of immunoglobulin banding patterns. These laboratory tests are now considered obligatory for any patient in whom demyelinating disease is suspected as the cause of neurological dysfunction. Cerebrospinal fluid protein data can also be helpful in quantitating the permeability of the blood/cerebrospinal fluid barrier in many inflammatory or infectious central nervous system disorders. Assays of individual proteins in urine can help distinguish between different types of proteinuria, and can give quantitative data on the selectivity of the glomerulus and the reabsorbing capacity of the tubules. The protein content of saliva, synovial fluid, and milk has also been well characterized, and is clinically applicable to a wide range of disorders.
在过去十年中,免疫化学和电泳技术取得了重大进展,使得收集此前无法获得的生物体液中蛋白质的数据成为可能,极大地增进了我们对身体各个腔室中蛋白质生理学的理解,并为体液蛋白质分析的临床应用奠定了基础。最显著的进展是通过使用血清/脑脊液蛋白比率以及免疫球蛋白条带模式的形态学评估来诊断脱髓鞘疾病。对于任何疑似因脱髓鞘疾病导致神经功能障碍的患者,这些实验室检查现在被认为是必不可少的。脑脊液蛋白数据在许多炎症性或感染性中枢神经系统疾病中,对于定量血脑屏障的通透性也可能有所帮助。尿液中单个蛋白质的检测有助于区分不同类型的蛋白尿,并能提供关于肾小球选择性和肾小管重吸收能力的定量数据。唾液、滑液和乳汁中的蛋白质含量也已得到充分表征,并在临床上适用于多种疾病。